| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 04/29/2008 | US7364844 Use of the Krit1 gene in the field of angiogenesis |
| 04/29/2008 | US7364743 Nucleotide sequence encoding PTD and CEA fusion protein, TAT-CEA fusion protein, anti-tumor vaccine and pharmaceutical composition for treating tumor comprising the fusion protein |
| 04/29/2008 | US7364742 Respiratory syncytial virus antibody comprising at least one heavy chain variable region and at least one light chain variable region having specific amino acid sequences; encoding complementary nucleic acids, vectors, host cells, transgenic animals or plants |
| 04/29/2008 | US7364740 Genetic deletions are used as markers to distinguish between pathogenic and avirulent strains such as Mycobacterium and Bacillus Calmette-Guerin (BCG); immunoassay; vaccines; attenuation, genetic engineering; immunogenic pure polypeptide encoded by a nucleotide sequence comprising open reading frame |
| 04/29/2008 | US7364733 antibodies that bind to Activated CD4+ T-cells (ACT-4) receptors; diagnostic or therapeutic use for immune disorders; selective suppression of immune response; allograft rejection, graft versus host disease, autoimmune diseases, allergies |
| 04/29/2008 | US7364728 Genetically engineering organisms that produce proteins lethal to larvae of insects nucleotide sequences isolated from Bacillus popilliae encode two adjacent, putative genes; orf1 and cryhime; insecticides, larvicides, pesticides; beetles |
| 04/29/2008 | US7364727 Transcriptional regulatory element (TRE) sequence operably linked to virus replication gene; adenoviral vectors; selective cytotoxicity |
| 04/29/2008 | US7364724 Recombinant super-compound interferon |
| 04/29/2008 | CA2177952C Nucleosides and oligonucleotides containing boron clusters |
| 04/26/2008 | CA2563179A1 Quantification of microsphere suspension hybridization and uses thereof |
| 04/24/2008 | WO2008048355A2 Population scale hla-typing and uses thereof |
| 04/24/2008 | WO2008048306A2 Influenza a virus vaccines and inhibitors |
| 04/24/2008 | WO2008046182A1 Stroma derived predictor of breast cancer |
| 04/24/2008 | WO2007112754A3 Pharmaceutical compositions comprising anti-mirna antisense oligonucleotides |
| 04/24/2008 | WO2007109067A3 Non-random aptamer libraries and methods for making |
| 04/24/2008 | US20080097092 Short interfering RNA sequences for use in treatment and prevention of diabetes, alzheimer's and cell proliferative disorders |
| 04/24/2008 | US20080097091 Short interfering RNA sequences for use in treatment and prevention of diabetes, alzheimer's and cell proliferative disorders |
| 04/24/2008 | US20080097090 Functional and hyperfunctional siRNA directed against Bcl-2 |
| 04/24/2008 | US20080097089 Short interfering RNA sequences for use as therapeutic tools in treatment of cancer, diabetes and nervous system disorders |
| 04/24/2008 | US20080097088 Expression elements |
| 04/24/2008 | US20080097087 Micelles; complexes; stability; MALDI-TOF-MS |
| 04/24/2008 | US20080097083 Granulocyte cell stimulating factor (G-CSF), erythropoietin, interferon, and growth hormone |
| 04/24/2008 | US20080097082 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia |
| 04/24/2008 | US20080097028 Polymeric beads for oligomer synthesis |
| 04/24/2008 | US20080096981 modulating activities associated with the IL-9 pathway for the treatment of atopic allergies like asthma; autoimmune diseases; new genes tightly expressed in association with an inflammatory response in the airways mediated by type 2 helper T-cells (TH). These genes have been designated TH2AF1 |
| 04/24/2008 | US20080096839 DNA vector encoding the RNA molecules and synthesized siRNA molecules; gene expression and viral replication inhibition |
| 04/24/2008 | US20080096838 Guanosine rich oligonucleotides and methods of inducing apoptosis in tumor cells |
| 04/24/2008 | US20080096836 Contacting sample of heterogenous protein from blood, lymph or cerebrospinal fluid or protein expression library such as a wound site-, a lambda wound site expression-, or a phage display library with compound from saliva or salivary glands of a blood-feeding parasite; isolating ligand or receptor |
| 04/24/2008 | US20080096835 Inhibitory oligonucleotides targeted to BCL-2 |
| 04/24/2008 | US20080096833 Diagnostic drugs and kits; coded for human proto-oncogene Pim-3, an antibody specific thereto; short interence RNA; genetic engineering |
| 04/24/2008 | US20080096821 Cytostatin II |
| 04/24/2008 | US20080096818 administering polypeptides comprising beta amyloid fragments, to induce immunogenic response against amyloid deposits; prophylaxios and therapy of Alzheimer's disease |
| 04/24/2008 | US20080096810 Cab Molecules |
| 04/24/2008 | US20080096796 Peptides That Stimulate Cell Survival and Axon Regeneration |
| 04/24/2008 | US20080096769 Phage displayed trp cage ligands |
| 04/24/2008 | US20080096279 Expression vector comprising reporter enzyme for enhanced expression in microorganism; improving heterologouus gene expression in host cells |
| 04/24/2008 | US20080096277 Expession vector comprising nucleotide sequences which code and enhance prolamin polypeptide transcription and RNA interfereing sequence which decrease expression of preferential storage proteins in seeds |
| 04/24/2008 | US20080096276 Expression vector comprising nucleotide sequences coding undecaprenyl diphosphate and dehydrodolichyl diphosphate synthases for use as tool in enhancing plant defenses |
| 04/24/2008 | US20080096274 Recombinant alphavirus vectors and methods of using same |
| 04/24/2008 | US20080096264 Attenuated parainfluenza virus (PIV) vaccines |
| 04/24/2008 | US20080096259 Method of aminoacylating tRNA |
| 04/24/2008 | US20080096256 Method for gene expression |
| 04/24/2008 | US20080096253 Methods of making nanotechnological and macromolecular biomimetic structures |
| 04/24/2008 | US20080096248 Grampositive bacterial polypeptide comprising toxin translocation domain for use as therapeutic targeting tools in cosmetic and the treatment of nervous system and nervous system disorders |
| 04/24/2008 | US20080096247 Nucleic acids encoding duramycin |
| 04/24/2008 | US20080096245 Cystatin-based peptide tags for the expression and purification of bioactive peptides |
| 04/24/2008 | US20080096239 Orphan Nuclear Receptor |
| 04/24/2008 | US20080096228 Using lymphocyte enhancer factor-1 (LEF-1) expression as evaluative tool in diagnosing cell proliferative disorders |
| 04/24/2008 | US20080096224 Fusion proteins comprising pleckstrin homology domain of Akt (protein kinase B) and a pseudoligand containing acidic amino acid residues, sandwiched between resonance energy transfer (RET) pairs, such as cyan and yellow mutants of green fluorescent protein; high throughput assay; drug screening |
| 04/24/2008 | US20080096215 Using sulfatase gene expression as evaluative tool in detection, prevention and treatment of cell proliferative disorders |
| 04/24/2008 | US20080096213 Identifying unmethylated DNA sequence using bisulfite treatment; diagnosing cell proliferative disorders |
| 04/24/2008 | US20080096208 Biomarkers for assessing response to c-met treatment |
| 04/24/2008 | US20080096207 Leptin and Growth Hormone Receptor Gene Markers Associated with Rearing, Carcass Traits and Productive Life in Cattle |
| 04/24/2008 | US20080096205 Diagnostic methods and kits for colorectal cancer |
| 04/24/2008 | US20080096201 Glyceraldehyde-3-phosphate dehydrogenase and Saframycin A/dna complexes; evaluation of microbiocidal and antiproliferative activity; kits |
| 04/24/2008 | US20080096200 Methods for detection of a target nucleic acid by capture using multi-subunit probes |
| 04/24/2008 | US20080096198 Primer Having Promoter Region Added Thereto |
| 04/24/2008 | US20080096197 Compounds and Methods for Assessment of Microsatellite Instability (Msi) Status |
| 04/24/2008 | US20080096196 Method for Analyzing Samples by Means of Hybridization |
| 04/24/2008 | US20080096193 Quantitative analysis; optical properties; kits |
| 04/24/2008 | US20080096190 Sequences Diagnostic For Shrimp Pathogens |
| 04/24/2008 | US20080096187 Molecular Scaffolds for HIV-1 Epitopes |
| 04/24/2008 | US20080096186 Pcr primer set for detecting severe acute respiratory syndrome (sars)-coronavirus, method and kit for detecting sars-coronavirus using the same |
| 04/24/2008 | US20080095915 Delta-8 Desaturases And Their Use In Making Polyunsaturated Fatty Acids |
| 04/24/2008 | US20080095833 Immunogens; expression cassettes; gag genes; tat proteins; DNA vaccines; vpr genes; rev genes; envelope genes; antigen presenting cells; liposomes |
| 04/24/2008 | US20080095796 IBD virus TY2 strain or a passage strain of said viral strain allows for production of a vaccine that is efficacious to IBD variant viral strains that may have new properties not protectable by the conventional vaccines |
| 04/24/2008 | US20080095791 Nucleotide sequences coding human immunodeficiency viral envelope protein fusion comprising epitopes from three viral variants for use in developing antibodies to prevent viral infection |
| 04/24/2008 | US20080095776 Erythropoietin receptor binding antibodies |
| 04/24/2008 | US20080095770 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
| 04/24/2008 | US20080095758 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| 04/24/2008 | CA2699434A1 Stroma derived predictor of breast cancer |
| 04/24/2008 | CA2666667A1 Generating an immune response by inducing cd40 and pattern recognition receptors |
| 04/24/2008 | CA2666555A1 Synthesis and compositions of nucleic acids comprising 2'-terminator nucleotides |
| 04/24/2008 | CA2666507A1 Synthetic antibodies |
| 04/24/2008 | CA2643771A1 Population scale hla-typing and uses thereof |
| 04/23/2008 | EP1914319A2 Polymorphisms and new genes in the region of the human hemochromatosis gene |
| 04/23/2008 | EP1914238A2 Methods for measuring physical characteristics of nucleic acids by microscope imaging |
| 04/23/2008 | EP1913158A2 Multiplex detection of nucleic acids |
| 04/23/2008 | EP1913149A2 Targeted integration and expression of exogenous nucleic acid sequences |
| 04/23/2008 | EP1913011A2 Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase |
| 04/23/2008 | EP1786826A4 Thymic stromal lymphopoietin promoter and uses therefor |
| 04/23/2008 | EP1774033A4 Multiplexing assays for analyte detection |
| 04/23/2008 | EP1723160A4 Toll-like receptor 2 (tlr-2) haplotypes predict outcome of patients |
| 04/23/2008 | EP1699822B1 Il-7 fusion proteins with antibody portions, their preparation and their use |
| 04/23/2008 | EP1660515A4 Nucleic acid analysis method conducted in small reaction volumes |
| 04/23/2008 | EP1639137A4 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 04/23/2008 | EP1142591B1 Gene carriers |
| 04/23/2008 | EP0763116B2 Recombinant viruses, preparation and use thereof in gene therapy |
| 04/23/2008 | CN101166760A A molecule and chimeric molecules thereof |
| 04/23/2008 | CN101166759A T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof |
| 04/23/2008 | CN101166757A A novel chimeric polypeptide and use thereof |
| 04/23/2008 | CN101166752A Compositions and methods for inhibiting white spot syndrome virus (WSSV) infection |
| 04/23/2008 | CN101166751A Inhibitor of peroxisome proliferator-activated receptor alpha coactivator 1 |
| 04/23/2008 | CN100383161C Polypeptide for inhibiting gelatin enzyme A activity and its preparation method and application |
| 04/23/2008 | CN100383156C Preparation method of DNA pretreatment buffer liquid, thallus DNA and nucleic acid DNA |
| 04/22/2008 | US7361821 Using oligonucleotide probes for detection, identification and/or sequencing of nucleic acids and/or biomolecules; for use in medical diagnostics, forensics, toxicology, pathology, biological warfare |
| 04/22/2008 | US7361807 nucleotide sequence that code polypeptides having 3-oxoacyl-[acyl carrier protein] reductase (OAR) activity; biosynthesis of polylactones in transformed plants and host cells |
| 04/22/2008 | US7361752 chemically modified oligonucleotides; double stranded iRNA agent; comprising a cholesterol moiety; increased stability in a biological sample |
| 04/22/2008 | US7361750 Comprises streptococcal protein which inhibits hemolysis (SIC) for preventing and treating glomreulonephritis and rheumatic fever; genetic vaccines |
| 04/22/2008 | US7361748 Protease for identifying modulators for treatment and prevention of thrombocytopenia and liver disorders |